Signed documents are available upon request.
It defines areas of potential conflict of interest and identifies when disclosure of interests should be provided to ensure appropriate level of transparency and eventually place limitations on participation in EORTC activities.
Download PDFIt provides guidance on how to ensure the protection of the rights, safety and well-being of trial subjects pertaining to all EORTC activities within the European framework. This policy also ensures homogeneous conduct of studies involving biological material from patients who have participated in EORTC clinical trials.
Download PDFIt describes the review of research misconduct allegation and the subsequent investigation and outcome.
Download PDFIt outlines the EORTC policy on intergroup studies in order to facilitate this type of collaboration.
Download PDFIts describes what is an EORTC labeled meeting and conditions to use the EORTC logo.
Download PDFIt describes the responsibilities of the Scientific Audit Committee (SAC) and the process of EORTC group review.
Download PDFIt defines the terms and conditions under which electronic records of individual data from all or from subsets of the patients from EORTC studies may be shared with other organizations or individual researchers for the purpose of scientific research projects or may be posted on data repositories.
Download Policy Terms of UseThis document defines the EORTC policy regarding release and publication of all results from EORTC clinical studies and research projects.
This policy covers timing of release of results, authorship and acknowledgements rules for abstracts/presentations and peer-reviewed publications, and the process of review by EORTC Headquarters.
Download PDFIt describes the principles for site activation and start of recruitment in EORTC studies defining the process and timelines by which EORTC will grant authorization to sites to join a particular study. It also defines the decisions that can be taken towards non-performing sites during study activation and start of recruitment on site.
The steps described in this policy require high involvement including optimal coordination, engagement and cooperation from the joining sites.
Download PDFEORTC as a clinical research organisation needs to create a structure for the development and approval of documents that are published as recommendations. These documents are encouraged, as they will increase the EORTC’s visibility and quality of cancer care and should be published in a peer reviewed journal. The forms of these recommendations need to comply with international references for level of evidence and be in compliance with EORTC missions. This policy does not apply to individual studies but to the recommendations dedicated to a specific clinical or methodological situation.
Download PDFIt defines the collection or acquisition, processing, and storage of Human Biological Material (HBM) in EORTC clinical studies and research projects, as well as the conditions of use of the HBM.
The principles developed in this policy apply to all EORTC clinical studies and research projects, as well as intergroup studies for which EORTC is the coordinating group.
EORTC legitimate mission is to coordinate and conduct throughout its network and in collaboration with third parties,
international prospective and retrospective translational and clinical research to improve the standard of cancer
treatment for patients. Aside this primary mission, EORTC also develops and improves research methodologies and
tools and organizes educational events and courses. Last, but not the least, EORTC also raises funds to support its
activities.
This policy describes how EORTC ensure protection of personal data it processes as a data controller and as a data
processor.
This document defines the policy of EORTC in regard to reporting genetic findings to the treating clinicians. The clinician will decide if and how to report those findings to the patient.
Download PDFThe objective of this policy is to describe the principles for membership to the EORTC. It defines the types, the process for application, approval, review and renewal. It also defines the decisions that can be taken towards members that breach the “Terms and Conditions“.
The steps described in this policy require compliance by all Groups and Task Forces, all referred to as “Groups” in this policy.
Download PDFIt describes the EORTC policy for the use of Independent Data Monitoring Committees (IDMC) in EORTC sponsored studies. It can be used as a reference document for studies sponsored by non-EORTC organizations if of interest for the conduct of such studies.
Download PDFIt describes the rules to be followed for initiating, reviewing, endorsing and developing a study at or with EORTC such that it is ready to start study activation processes.
Download PDFIt describes the independent review of translational research (TR) projects at EORTC, through the Translational Review Committee (TRC).
Download PDFIt describes the rules to be followed for submission of project proposals to a research funding programs (herein referred to as calls) to optimally align EORTC strategy, operations and resources with the criteria, requirements and application steps of the funders.
Download PDF
